3 Figure S1 . Experimental ECD spectrum of 2(S)-8-(3-methylbut-2-en-1-yl)-6,7,4′trihydroxyflavanone (1).
4 Figure S2 . 1 H NMR spectrum of 2(S)-8-(3-methylbut-2-en-1-yl)-6,7,4′-trihydroxyflavanone (1) (400 MHz; acetone-d6).
5 Figure S3 . 13 C NMR spectrum of 2(S)-8-(3-methylbut-2-en-1-yl)-6,7,4′-trihydroxyflavanone (1) (100 MHz; acetone-d6).
6 Figure S4 . HSQC spectrum of 2(S)-8-(3-methylbut-2-en-1-yl)-6,7,4′-trihydroxyflavanone (1) (400 MHz; acetone-d6).
7 Figure S5 . HMBC spectrum of 2(S)-8-(3-methylbut-2-en-1-yl)-6,7,4′-trihydroxyflavanone (1) (400 MHz; acetone-d6).
8 Figure S6 . COSY spectrum of 2(S)-8-(3-methylbut-2-en-1-yl)-6,7,4′-trihydroxyflavanone (1) (400 MHz; acetone-d6).
9 Figure S7 . 1 H NMR spectrum of (+)-medicarpin (2) (400 MHz; acetone-d6).
10 Figure S8 . 13 C NMR spectrum of (+)-medicarpin (2) (100 MHz; acetone-d6).
11 Figure S9 . HSQC spectrum of (+)-medicarpin (2) (400 MHz; acetone-d6). Figure S10 . HMBC spectrum of (+)-medicarpin (2) (400 MHz; acetone-d6).
13 Figure S11 . COSY spectrum of (+)-medicarpin (2) (400 MHz; acetone-d6).
14 Figure S12 . 1 H NMR spectrum of (+)-maackiain (3) (400 MHz; acetone-d6).
15 Figure S13 . 13 C NMR spectrum of (+)-maackiain (3) (100 MHz; acetone-d6). Figure S14 . HSQC spectrum of (+)-maackiain (3) (400 MHz; acetone-d6). Figure S15 . HMBC spectrum of (+)-maackiain (3) (400 MHz; acetone-d6).
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18 Figure S16 . COSY spectrum of (+)-maackiain (3) (400 MHz; acetone-d6).
19 Figure S17 . 1 H NMR spectrum of (-)-malheuran A (4) (400 MHz; acetone-d6).
20 Figure S18 . 13 C NMR spectrum of (-)-malheuran A (4) (100 MHz; acetone-d6).
21 Figure S19 . 1 H NMR spectrum of (-)-euchrenone a7 (5) (400 MHz; acetone-d6).
22 Figure S20 . 13 C NMR spectrum of (-)-euchrenone a7 (5) (100 MHz; acetone-d6).
23 Figure S21 . HSQC spectrum of (-)-euchrenone a7 (5) (400 MHz; acetone-d6).
24 Figure S22 . HMBC spectrum of (-)-euchrenone a7 (5) (400 MHz; acetone-d6).
25 Figure S23 . COSY spectrum of (-)-euchrenone a7 (5) (400 MHz; acetone-d6).
26 Figure S24 . 1 H NMR spectrum of (2S)-leachianone G (6) (400 MHz; acetone-d6).
27 Figure S25 . 13 C NMR spectrum of (2S)-leachianone G (6) (100 MHz; acetone-d6).
28 Figure S26 . HSQC spectrum of (2S)-leachianone G (6) (400 MHz; acetone-d6).
29 Figure S27 . HMBC spectrum of (2S)-leachianone G (6) (400 MHz; acetone-d6).
30 Figure S28 . COSY spectrum of (2S)-leachianone G (6) (400 MHz; acetone-d6).
31 Figure S29 . 1 H NMR spectrum of (-)-malheuran B (7) (400 MHz; acetone-d6).
32 Figure S30 . 13 C NMR spectrum of (-)-malheuran B (7) (100 MHz; acetone-d6).
33 Figure S31 . 1 H NMR spectrum of (2S)-5'-(2-methylbut-3-en-2-yl)-8-(3-methylbut-2-en-1-yl)-5,7,2',4'-tetrahydoxyflavanone (8) (400 MHz; acetone-d6).
34 Figure S32 . 13 C NMR spectrum of (2S)-5'-(2-methylbut-3-en-2-yl)-8-(3-methylbut-2-en-1-yl)-5,7,2',4'-tetrahydoxyflavanone (8) (100 MHz; acetone-d6).
35 Figure S33 . 1 H NMR spectrum of (-)-deguelin (9) (400 MHz; acetone-d6).
36 Figure S34 . 13 C NMR spectrum of (-)-deguelin (9) (100 MHz; acetone-d6).
37 Figure S35 . HSQC spectrum of (-)-deguelin (9) (400 MHz; acetone-d6).
38 Figure S36 . HMBC spectrum of (-)-deguelin (9) (400 MHz; acetone-d6).
39 Figure S37 . COSY spectrum of (-)-deguelin (9) (400 MHz; acetone-d6).
40 Figure S38 . 1 H NMR spectrum of (-)-tephrosin (10) (400 MHz; acetone-d6). Figure S39 . 13 C NMR spectrum of (-)-tephrosin (10) (100 MHz; acetone-d6). 
Figure S32
. 13 C NMR spectrum of (2S)-5'-(2-methylbut-3-en-2-yl)-8-(3-methylbut-2-en-1-yl)-5,7,2',4'tetrahydoxyflavanone (8) (100 MHz; acetone-d6). Figure S33 . 1 H NMR spectrum of (-)-deguelin (9) (400 MHz; acetone-d6). Figure S34 . 13 C NMR spectrum of (-)-deguelin (9) (100 MHz; acetone-d6). Figure S35 . HSQC spectrum of (-)-deguelin (9) (400 MHz; acetone-d6). Figure S36 . HMBC spectrum of (-)-deguelin (9) (400 MHz; acetone-d6). Figure S37 . COSY spectrum of (-)-deguelin (9) (400 MHz; acetone-d6). Figure S38 . 1 H NMR spectrum of (-)-tephrosin (10) (400 MHz; acetone-d6). Figure S39 . 13 C NMR spectrum of (-)-tephrosin (10) (100 MHz; acetone-d6).
